Table 4 Somatic and mental morbidity of cancer survivors and controls
Variables | Survivors (N = 334) | Controls (N = 1,670) | p-value | Effect size |
|---|---|---|---|---|
Self-rated health | <0.001* | 0.26 | ||
Good health | 151 (46) | 971 (59) | ||
Poor health | 178 (54) | 687 (41) | ||
Functional impairment | ||||
Physical impairment | 76 (23) | 230 (13) | <0.001* | 0.26 |
Mental impairment | 14 (4) | 62 (4) | 0.62* | |
Somatic diseases | ||||
Infarction, angina or stroke | 44 (13) | 223 (13) | 0.85* | |
Diabetes | 14 (4) | 73 (4) | 0.83* | |
Thyroid diseases | 48 (14) | 121 (7) | 0.001* | 0.23 |
Osteoporosis | 17 (5) | 65 (4) | 0.84* | |
Arthritis, arthrosis | 80 (24) | 408 (24) | 0.34* | |
Musculo-skeletal diseases | 54 (16) | 207 (12) | 0.07* | |
≥1 comorbid disease(s) | 169 (51) | 809 (48) | 0.99* | |
Significant somatic symptoms | ||||
Muscular pain and stiffness affecting | ||||
activities of daily living last month | 66 (20) | 322 (19) | 0.70* | |
Gastrointestinal symptoms last year | 36 (11) | 165 (10) | 0.82* | |
Headache last year | 76 (23) | 428 (26) | 0.19* | |
Regular use of medication last year | ||||
Daily use of any medication | 190 (57) | 822 (49) | 0.01* | 0.16 |
Analgesics | 45 (14) | 179 (11) | 0.15* | |
Psychotropics | 56 (17) | 187 (11) | 0.02* | 0.17 |
Antihypertensives | 75 (23) | 361 (22) | 0.98* | |
Mental variables | ||||
HADS-Anxiety, mean (SD)a | 4.8 (3.8) | 4.0 (3.4) | 0.001* | 0.20 |
HADS-Anxiety caseness, N (%) | 77 (25) | 208 (13) | <0.001* | 0.31 |
HADS-Depression, mean (SD) a | 4.2 (3.3) | 4.1 (3.2) | 0.41* | |
HADS-Depression caseness, N (%) | 47 (15) | 230 (14) | 0.73* | |
Self-esteem score, mean (SD) | 5.6 (1.9) | 5.7 (1.6) | 0.39* | |
Sleeping problems, N (%) | 89 (29) | 385 (24) | 0.35* | |
Alcohol problems, N (%) | 25 (8) | 147 (8) | 0.57* | |
Lifestyle variables | ||||
BMI, mean (SD) | 27.6 (4.5) | 27.4 (4.2) | 0.84* | |
Physical activity, N (%) | 0.42* | |||
Minimal | 86 (31) | 475 (34) | ||
Moderate or more | 188 (69) | 930 (66) | ||
Daily smoker | 64 (23) | 308 (22) | 0.49* | |
Framingham risk score | ||||
Framingham sum score, mean (SD) | 16.4 (2.9) | 16.0 (2.9) | 0.01 | 0.14 |
Framingham risk >20%, N (%) | 198 (58) | 867 (52) | 0.12 |